Skip to main content

Software Effective Solutions "MEDCANA" (OTC: SFJW) Begins Full Crop Cycle Testing and Advances Infrastructure Development in Colombia

--News Direct--

McapMediaWire -- Software Effective Solutions (OTC: SFWJ) (“The Company”, “SFWJ”), doing business as MedCana, is pleased to announce that it has begun full crop cycle testing across all five of its recently acquired companies in Medellín, Colombia. The goal of this testing phase is to train personnel, observe crop behavior, and ensure production processes work seamlessly. These tests are being conducted in smaller, controlled greenhouse environments before being scaled up to full production.

In addition to the crop cycle testing, MedCana has made significant progress in infrastructure development. Last week, the company finalized road and rainwater management systems, paving the way for earthmoving equipment to begin terracing and preparation for the first phase of the project.

"We are extremely happy with the progress we've made in the construction and development of our five companies in Colombia. We see no obstacles and remain satisfied with all results," said Gabriel Diaz, CEO of SFWJ.

MedCana's commitment to meticulous analysis and testing of all variables, including wind currents, humidity, soil, pests, and more, is reflected in the success of its initial infrastructure analysis, which has covered geological, hydrological, and environmental factors.

The recent acquisition of Tokan Corp's assets, a software company focused on creating an ERP platform for the cannabis industry, and Eko2O S.A.S., a greenhouse design and distribution company, has positioned MedCana for explosive growth in the region. The expertise and industry knowledge of Juan Ricardo Velez, CEO of Eko2O, has also contributed to dramatically decreasing costs for MedCana's subsidiaries in the region.

ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. With a recent acquisition of a software company, MedCana expanded its offering to provide traceability from plant to product. The company's initial focus is on developing clients and companies in Latin America, with an emphasis on Colombia, and forming partnerships with laboratories, research facilities, and hospitals worldwide.

As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for future growth, ensuring the highest quality pharmaceutical cannabis products and raw material for its customers, and maximizing shareholder value.


This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


Jose Gabriel Diaz, CEO

Contact Details


Company Website

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.